Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Amino acid gels may help preserve muscle in aging

NCT ID NCT07754760

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 10, 2026 · Last updated Aug 11, 2026 · Updated 1 time

Summary

This trial tests whether taking an essential amino acid supplement with a standard-protein breakfast increases the amount of amino acids in the blood of healthy adults aged 60 and older. Participants receive either an amino acid gel or a placebo on separate occasions, and blood samples are taken to measure amino acid levels. The goal is to find which amino acid mix works best to support muscle protein synthesis, which could help prevent age-related muscle loss.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Essential amino acid supplement
What this could lead to
If successful, this could help develop simple dietary strategies to preserve muscle mass and function in older adults, potentially reducing the risk of sarcopenia.
What could go wrong
This is a small, early-stage trial with only 10 participants, so results may not apply broadly. The study measures blood amino acid levels, not actual muscle outcomes, so benefits remain uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

10 people

The number who actually took part.

Started

Jun 2022

Finished

Dec 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 60 years or older * Able and willing to provide written informed consent for the study * Capable of ingesting the oral supplement Exclusion Criteria: * Incapable of understanding the study and providing informed consent * Incapable of ingesting the oral supplement * Any known cardiovascular disease * Any known kidney problems or requiring dialysis treatment * Any known health issue which may affect the uptake and concentration of plasma amino acids * Suffer from coeliac disease * Being allergic to any of the ingredients in the supplements or standardised breakfast (e.g., nuts and/or oats, wheat, barley, soya) * Vegan * Lactose intolerant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Older adults without any specific clinical condition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Carnegie School of Sport

    Leeds, West Yorkshire, LS6 3FH, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.